TheraCell and AlloSource Issued U.S. Patent for Bone Fiber Technology

By Julie A. Vetalice

TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource's AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.

AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.

AlloSource launched AlloFuse Cortical Fiber and Fiber Boat allografts in 2Q16.

Sources: AlloSource; ORTHOWORLD Inc.

 

Product Labels: Bone Graft Materials/DBM

Tags: Patent